SILICON2 Co., Ltd. (KOSDAQ:257720)
South Korea · Delayed Price · Currency is KRW 42,650
-400 (-0.93%)
At close: Apr 10, 2026
SILICON2 Revenue
In the year 2025, SILICON2 had annual revenue of 1.12T KRW with 61.42% growth. SILICON2 had revenue of 305.95B in the quarter ending December 31, 2025, with 76.28% growth.
Revenue
1.12T
Revenue Growth
+61.42%
P/S Ratio
2.34
Revenue / Employee
4.04B
Employees
276
Market Cap
2.61T
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.12T | 424.76B | 61.42% |
| Dec 31, 2024 | 691.52B | 348.66B | 101.69% |
| Dec 31, 2023 | 342.86B | 177.59B | 107.45% |
| Dec 31, 2022 | 165.27B | 34.27B | 26.16% |
| Dec 31, 2021 | 131.00B | 31.60B | 31.79% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| SIMMTECH | 1.41T |
| Dongjin Semichem | 1.19T |
| Seojin System Co.,Ltd | 1.07T |
| PSK Inc. | 457.21B |
| Hugel | 425.11B |
| SPG Co., Ltd. | 341.67B |
| Tokai Carbon Korea | 301.33B |
| Celltrion Pharm | 274.73B |